Shire’s Chief Executive Officer, Flemming Ornskov, MD will participate at the Goldman Sachs 35th Annual Global Healthcare Conference on Thursday, June 12th at 10:00 am PT/18:00 BST. Investors may access a live audio webcast of the presentation at .
For further information please contact:
+1 781 482 0945
+44 1256 894157
NOTES TO EDITORS
Shire enables people with life-altering conditions to lead better lives.
Our strategy is to focus on developing and marketing innovative specialty medicines to meet significant unmet patient needs.
We focus on providing treatments in Neuroscience, Rare Diseases, Gastrointestinal and Internal Medicine and we are developing treatments for symptomatic conditions treated by specialist physicians in other targeted therapeutic areas, such as Ophthalmology.
Click here for the PDF version of this press release.